Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
8.09
Oct 30 • 3:56 PM ET Dollar change-1.45 Percentage change(-15.20%)
Aftermarket Close
8.15
Aftermarket • 7:30 PM ET Dollar change+0.06 Percentage change(0.74%)
Index
-
Market Cap
127.40M
Enterprise Value
118.56M
Income
-21.18M
Sales
47.90M
Book/sh
59.55
Cash/sh
0.73
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
471
IPO
Jan 12, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
2.66
P/B
0.14
P/C
11.03
P/FCF
87.26
EV/EBITDA
-
EV/Sales
2.48
Quick Ratio
0.65
Current Ratio
1.25
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-4.80
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-16.38% -5.39%
EPS Y/Y TTM
43.66%
Sales Y/Y TTM
78.43%
EPS Q/Q
58.37%
Sales Q/Q
69.76%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
72.48%
Insider Trans
0.00%
Inst Own
0.09%
Inst Trans
-
ROA
-6.58%
ROE
-7.30%
ROIC
-5.32%
Gross Margin
12.81%
Oper. Margin
-23.42%
Profit Margin
-44.22%
SMA20
-12.02%
SMA50
-4.32%
SMA200
-58.89%
Trades
Shs Outstand
6.02M
Shs Float
3.67M
52W High
302.40 -97.32%
52W Low
6.45 25.43%
Volatility
8.70% 14.35%
ATR (14)
1.12
RSI (14)
44.76
Beta
1.94
Rel Volume
0.04
Avg Volume
8.11K
Volume
299
Perf Week
3.06%
Perf Month
3.45%
Perf Quarter
-7.33%
Perf Half Y
-10.41%
Perf YTD
-92.69%
Perf Year
-97.04%
Perf 3Y
-90.53%
Perf 5Y
-98.51%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
9.54
Price
8.09
Change %
-15.20%
BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.
Co-Chief Executive Officer & DirectorMs. Huandi Zhao
Co-Chief Executive OfficerMs. Li Hong
Chief Financial OfficerMs. Yaxuan Zhai